🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

6 recruiting trials

for Biomarkers of Diabetic Retinopathy

Study of Natural Course Progression of Diabetic Retinopathy NCT06269419n/a1 site📍 Chengdu Jie Li Biomarker of Diabetic Retinopathy NCT05079399n/a3 sites📍 Carmel📍 Indianapolis📍 Indianapolis Indiana University · Tests: Blood draw Longitudinal Observational Study of Diabetic Retinopathy Progression in Type 2 Diabetes Patients NCT07458516n/a1 site📍 Coimbra Association for Innovation and Biomedical Research on Light… Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab NCT07520045NA1 site📍 Osijek Osijek University Hospital · Tests: Faricimab, Biosimilar ranibizumab Analysis of Biomarkers From Patients With Chorioretinal Diseases NCT02026843n/a1 site📍 Daegu Kyungpook National University Hospital · Tests: Chorioretinal diseases Proteomic Biomarker Identification in Age-Related Macular Degeneration, Diabetic Retinopathy and Retinal Detachment NCT07500324NA1 site📍 Roma Fondazione G.B. Bietti, IRCCS · Tests: Biological Sample Collection
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy